Ruiqiong Ma

753 total citations
45 papers, 513 citations indexed

About

Ruiqiong Ma is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Ruiqiong Ma has authored 45 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 14 papers in Obstetrics and Gynecology and 9 papers in Molecular Biology. Recurrent topics in Ruiqiong Ma's work include Ovarian cancer diagnosis and treatment (10 papers), Endometriosis Research and Treatment (9 papers) and Laser-Matter Interactions and Applications (6 papers). Ruiqiong Ma is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometriosis Research and Treatment (9 papers) and Laser-Matter Interactions and Applications (6 papers). Ruiqiong Ma collaborates with scholars based in China, United States and Canada. Ruiqiong Ma's co-authors include Xiaohong Chang, Hongyan Cheng, Xue Ye, Zi Yang, Heng Cui, Honglan Zhu, Heng Cui, Heng Cui, Hui Li and Chen Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Physical Review A and Frontiers in Immunology.

In The Last Decade

Ruiqiong Ma

43 papers receiving 502 citations

Peers

Countries citing papers authored by Ruiqiong Ma

Since Specialization

Citations

This map shows the geographic impact of Ruiqiong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqiong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqiong Ma more than expected).

Fields of papers citing papers by Ruiqiong Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqiong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqiong Ma. The network helps show where Ruiqiong Ma may publish in the future.

Co-authorship network of co-authors of Ruiqiong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqiong Ma. A scholar is included among the top collaborators of Ruiqiong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqiong Ma. Ruiqiong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unlocking the future: Mitochondrial genes and neural networks in predicting ovarian cancer prognosis and immunotherapy response 2024 ·World Journal of Clinical Oncology ·(unknown), Yuanming Pan, Wěi Li, Ruiqiong Ma, Jianliu Wang	1
2	Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes 2022 ·Frontiers in Cell and Developmental Biology ·Xiaoyan Shen, (unknown), Ruiqiong Ma, Xiaoping Li, Jianliu Wang	7
3	FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway 2022 ·Frontiers in Endocrinology ·Hui Li, (unknown), Hongyan Cheng, Xue Ye, Ruiqiong Ma, Honglan Zhu, Xiaohong Chang	32
4	Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer 2021 ·Frontiers in Immunology ·Hongyan Cheng, Ruiqiong Ma, Shang Wang, Yu Wang, Yingchun Li, (unknown), (unknown), (unknown), Honglan Zhu, Ye Xue, (unknown), Yonghua Zhang, Shufen Li, Yonghong Zhao, Yi Li, Heng Cui, Xiaohong Chang	3
5	Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study 2021 ·Journal of Ovarian Research ·Ling Zhou, (unknown), Lin Dai, Honglan Zhu, Xue Ye, Shang Wang, Hongyan Cheng, Ruiqiong Ma, Huiping Liu, Heng Cui, Xiaohong Chang	26
6	Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging 2020 ·World Journal of Surgical Oncology ·Junchen Chen, Chen Zhang, (unknown), Xiaohong Chang, Ruiqiong Ma, Xue Ye, Hongyan Cheng, Yi Li, Heng Cui	8
7	Near‐infrared dye‐labeled antibody COC183B2 enables detection of tiny metastatic ovarian cancer and optimizes fluorescence‐guided surgery 2020 ·Journal of Surgical Oncology ·Junchen Chen, (unknown), Hui Li, Chen Zhang, Xiaohong Chang, Ruiqiong Ma, Hongyan Cheng, (unknown), Heng Cui, Yi Li	4
8	Fibrinogen alpha chain promotes the migration and invasion of human endometrial stromal cells in endometriosis through focal adhesion kinase/protein kinase B/matrix metallopeptidase 2 pathway† 2020 ·Biology of Reproduction ·Hui Li, Ruiqiong Ma, Hongyan Cheng, Xue Ye, Honglan Zhu, Xiaohong Chang	12
9	Aberrant expression of CHL1 gene and long non-coding RNA CHL1-AS1, CHL1-AS2 in ovarian endometriosis 2019 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Chen Zhang, Wei Wu, Xue Ye, Ruiqiong Ma, Jianjun Luo, Honglan Zhu, Xiaohong Chang	21
10	Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging 2019 ·Chinese Journal of Cancer Research ·Chen Zhang, Xinyu Ling, (unknown), Cunzhong Yuan, Hongyan Cheng, Xue Ye, Ruiqiong Ma, Yinli Zhang, Yi Li, Xiaohong Chang, Beihua Kong, Tao Liu, Heng Cui	8
11	Fibrinogen alpha chain is up-regulated and affects the pathogenesis of endometriosis 2019 ·Reproductive BioMedicine Online ·Ying Chen, Hui Li, Hongyan Cheng, Ruiqiong Ma, Xue Ye, Heng Cui, (unknown), Xiaohong Chang	14
12	Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer 2018 ·Archives of Gynecology and Obstetrics ·Ruiqiong Ma, (unknown), Xue Ye, Hongyan Cheng, Kunkun Sun, Xiaohong Chang, Heng Cui	11
13	IGHG1 promotes motility likely through epithelial-mesenchymal transition in ovarian cancer 2018 ·Chinese Journal of Cancer Research ·(unknown), (unknown), (unknown), Hongyan Cheng, Ruiqiong Ma, Xiaohong Chang, Chengchao Shou, Heng Cui	11
14	Construction, expression, and function of 6B11ScFv–mIL-12, a fusion protein that attacks human ovarian carcinoma 2015 ·Medical Oncology ·Hongyan Cheng, Xue Ye, Xiaohong Chang, Ruiqiong Ma, (unknown), (unknown), Menglei Zhang, Kai Liu, Heng Cui, Jianli Sang	4
15	Low Programmed Cell Death 5 Expression is a Prognostic Factor in Ovarian Cancer 2015 ·Chinese Medical Journal ·Li Gao, Xue Ye, Ruiqiong Ma, Hongyan Cheng, (unknown), Heng Cui, Lihui Wei, Xiaohong Chang	14
16	PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer 2015 ·Gynecologic Oncology ·Ruiqiong Ma, Xue Ye, Hongyan Cheng, Yu Ma, Heng Cui, Xiaohong Chang	21
17	Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model 2010 ·Chinese Medical Journal ·Ruiqiong Ma, (unknown), Zi Yang	37
18	Measurement of quantum states with incoherent light 2008 ·Acta Physica Sinica ·Ruiqiong Ma, (unknown), (unknown), (unknown)	1
19	Attosecond sum-frequency Raman-enhanced polarization beating by use of twin phase-sensitive color locking noisy light beams 2005 ·Journal of the Optical Society of America B ·Yanpeng Zhang, (unknown), Jianping Song, (unknown), Ruiqiong Ma, Hao Ge, (unknown), Keqing Lu	5
20	Rayleigh-enhanced attosecond sum-frequency polarization beats via twin color-locking noisy lights 2005 ·Physical Review A ·Yanpeng Zhang, (unknown), Long Li, Ruiqiong Ma, Jianping Song, (unknown), (unknown), (unknown), Hao Ge, Keqing Lu	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact